Research ArticleBasic Sciences
Tc-99m HMDP (Hydroxymethylene Diphosphonate): A Radiopharmaceutical for Skeletal and Acute Myocardial Infarct Imaging. II. Comparison of Tc-99m Hydroxymethylene Diphosphonate (HMDP) with Other Technetium-Labeled Bone-Imaging Agents in a Canine Model
John A. Bevan, Andrew J. Tofe, James J. Benedict, Marion D. Francis and Bobby L. Barnett
Journal of Nuclear Medicine October 1980, 21 (10) 967-970;
John A. Bevan
Andrew J. Tofe
James J. Benedict
Marion D. Francis


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Tc-99m HMDP (Hydroxymethylene Diphosphonate): A Radiopharmaceutical for Skeletal and Acute Myocardial Infarct Imaging. II. Comparison of Tc-99m Hydroxymethylene Diphosphonate (HMDP) with Other Technetium-Labeled Bone-Imaging Agents in a Canine Model
John A. Bevan, Andrew J. Tofe, James J. Benedict, Marion D. Francis, Bobby L. Barnett
Journal of Nuclear Medicine Oct 1980, 21 (10) 967-970;
Tc-99m HMDP (Hydroxymethylene Diphosphonate): A Radiopharmaceutical for Skeletal and Acute Myocardial Infarct Imaging. II. Comparison of Tc-99m Hydroxymethylene Diphosphonate (HMDP) with Other Technetium-Labeled Bone-Imaging Agents in a Canine Model
John A. Bevan, Andrew J. Tofe, James J. Benedict, Marion D. Francis, Bobby L. Barnett
Journal of Nuclear Medicine Oct 1980, 21 (10) 967-970;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.